As breast cancer is a heterogeneous disease which could be grouped into Luminal A, Luminal B, HER2-enriched, and Triple negative subtypes, we further explored the relationship of EZH2 and STAT3 expression with survival of patients in breast cancer subtypes (Figure S1). The gene discussed is EZH2; the disease is breast cancer.